Patents Assigned to Cross Bay, LLC
  • Composition and method for reducing blood glucose
    Patent number: 6884420
    Abstract: A composition for reducing blood sugar in humans in need thereof, contains Agaricus blazeii, alpha lipoic acid, transfer factor, polymannose, fenugreek, coenzyme Q-10, selenium, zinc, vitamin C, vitamin E, chromium and vanadium.
    Type: Grant
    Filed: May 19, 2003
    Date of Patent: April 26, 2005
    Assignee: Cross Bay, LLC
    Inventor: Darryl See
  • Composition and method for reducing blood glucose
    Publication number: 20040234513
    Abstract: A composition for reducing blood sugar in humans in need thereof, contains Agaricus blazeii, alpha lipoic acid, transfer factor, polymannose, fenugreek, coenzyme Q-10, selenium, zinc, vitamin C, vitamin E, chromium and vanadium.
    Type: Application
    Filed: May 19, 2003
    Publication date: November 25, 2004
    Applicant: Cross Bay, LLC
    Inventor: Darryl See